Jui Vyas

859 total citations
20 papers, 517 citations indexed

About

Jui Vyas is a scholar working on Dermatology, Economics and Econometrics and Immunology and Allergy. According to data from OpenAlex, Jui Vyas has authored 20 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Dermatology, 4 papers in Economics and Econometrics and 4 papers in Immunology and Allergy. Recurrent topics in Jui Vyas's work include Dermatology and Skin Diseases (12 papers), Allergic Rhinitis and Sensitization (4 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Jui Vyas is often cited by papers focused on Dermatology and Skin Diseases (12 papers), Allergic Rhinitis and Sensitization (4 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Jui Vyas collaborates with scholars based in United Kingdom, Denmark and Finland. Jui Vyas's co-authors include A.Y. Finlay, Faraz M Ali, Alberto Giannetti, Eugene Healy, Sakari Reitamo, Thomas Ruzicka, Thomas Bieber, Andreas Wollenberg, Mette Deleuran and Morad Lahfa and has published in prestigious journals such as British Journal of Dermatology, Allergy and BMJ Open.

In The Last Decade

Jui Vyas

18 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jui Vyas United Kingdom 9 395 277 93 78 42 20 517
Donald Lei United States 15 313 0.8× 239 0.9× 49 0.5× 129 1.7× 16 0.4× 37 498
Julianne A. Mann United States 8 348 0.9× 270 1.0× 59 0.6× 148 1.9× 7 0.2× 22 534
Seema P. Kini United States 7 257 0.7× 93 0.3× 44 0.5× 50 0.6× 7 0.2× 9 362
A. Fink‐Wagner Germany 5 927 2.3× 749 2.7× 66 0.7× 316 4.1× 21 0.5× 7 990
H. Heigel Germany 6 277 0.7× 118 0.4× 50 0.5× 102 1.3× 7 0.2× 6 392
Anne Le Rhun France 6 250 0.6× 192 0.7× 14 0.2× 89 1.1× 7 0.2× 15 360
Raveena Khanna United States 13 313 0.8× 94 0.3× 48 0.5× 75 1.0× 8 0.2× 31 392
Joanne N.G. Oude Elberink Netherlands 14 164 0.4× 610 2.2× 139 1.5× 153 2.0× 19 0.5× 17 689
Jordan Rosen United States 10 353 0.9× 149 0.5× 63 0.7× 97 1.2× 7 0.2× 25 479
Lauren Becker United States 6 291 0.7× 201 0.7× 87 0.9× 166 2.1× 9 0.2× 7 377

Countries citing papers authored by Jui Vyas

Since Specialization
Citations

This map shows the geographic impact of Jui Vyas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jui Vyas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jui Vyas more than expected).

Fields of papers citing papers by Jui Vyas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jui Vyas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jui Vyas. The network helps show where Jui Vyas may publish in the future.

Co-authorship network of co-authors of Jui Vyas

This figure shows the co-authorship network connecting the top 25 collaborators of Jui Vyas. A scholar is included among the top collaborators of Jui Vyas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jui Vyas. Jui Vyas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vyas, Jui, Jeffrey Johns, Amal N. Trivedi, et al.. (2025). Systematic review of the use of the Dermatology Life Quality Index in routine clinical practice: evidence from 287 articles across 56 countries. Clinical and Experimental Dermatology. 50(12). 2456–2465.
2.
Vyas, Jui, Jeffrey Johns, Faraz M Ali, et al.. (2024). P047 Dermatology Life Quality Index used as a standard in validation of 101 quality-of-life instruments: a systematic review. British Journal of Dermatology. 191(Supplement_1). i36–i36.
3.
Vyas, Jui, Jeffrey Johns, Faraz M Ali, et al.. (2024). The Dermatology Life Quality Index (DLQI) used as the benchmark in validation of 101 quality‐of‐life instruments: A systematic review. Journal of the European Academy of Dermatology and Venereology. 39(3). 631–679. 5 indexed citations
4.
Vyas, Jui, Jeffrey Johns, Faraz M Ali, et al.. (2024). A Systematic Review of 207 Studies Describing Validation Aspects of the Dermatology Life Quality Index. Acta Dermato Venereologica. 104. adv41120–adv41120. 3 indexed citations
5.
Vyas, Jui, et al.. (2024). Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Impact on Quality of Life (QoL) of Persons with ME/CFS. Medicina. 60(8). 1215–1215. 3 indexed citations
6.
Johns, Jeffrey, Jui Vyas, Faraz M Ali, et al.. (2024). The Dermatology Life Quality Index as the primary outcome in randomized clinical trials: a systematic review. British Journal of Dermatology. 191(4). 497–507. 2 indexed citations
7.
Vyas, Jui, Jeffrey Johns, Faraz M Ali, et al.. (2023). A systematic review of 454 randomized controlled trials using the Dermatology Life Quality Index: experience in 69 diseases and 43 countries. British Journal of Dermatology. 190(3). 315–339. 8 indexed citations
8.
Johns, Jeffrey, Jui Vyas, Faraz M Ali, et al.. (2023). P82 Validation of the dermatology life quality index (DLQI): a systematic review of the literature. British Journal of Dermatology. 188(Supplement_4). 1 indexed citations
10.
Vyas, Jui, et al.. (2021). Dermatological history and examination. Medicine. 49(6). 343–349. 2 indexed citations
11.
Finlay, A.Y., et al.. (2021). Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Major Impact on Lives of Both Patients and Family Members. Medicina. 57(1). 43–43. 13 indexed citations
12.
Vyas, Jui, et al.. (2020). A retrospective audit to assess the safety and efficacy of apremilast use in chronic plaque psoriasis. Future Healthcare Journal. 7(Suppl 1). s47–s48. 1 indexed citations
13.
Ali, Faraz M, Jui Vyas, & A.Y. Finlay. (2020). Counting the Burden: Atopic Dermatitis and Health-related Quality of Life. Acta Dermato Venereologica. 100(12). adv00161–adv00161. 109 indexed citations
14.
Vyas, Jui, et al.. (2017). Traction alopecia: A neglected entity in 2017. Indian Journal of Dermatology Venereology and Leprology. 83(6). 644–644. 15 indexed citations
15.
Ali, Faraz M, et al.. (2016). A systematic review of the use of quality-of-life instruments in randomized controlled trials for psoriasis. British Journal of Dermatology. 176(3). 577–593. 46 indexed citations
16.
Edwards, Alan M., Sharon Matthews, Syed Hasan Arshad, et al.. (2015). Long-term use of a 4% sodium cromoglicate cutaneous emulsion in the treatment of moderate to severe atopic dermatitis in children. Journal of Dermatological Treatment. 26(6). 541–547. 4 indexed citations
17.
Vyas, Jui, et al.. (2012). HTLV‐1‐associated infective dermatitis: updates on the pathogenesis. Experimental Dermatology. 21(11). 815–821. 31 indexed citations
18.
Wollenberg, Andreas, Sakari Reitamo, Giampiero Girolomoni, et al.. (2008). Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. Allergy. 63(7). 742–750. 157 indexed citations
19.
Wollenberg, Andreas, Sakari Reitamo, Francesco Atzori, et al.. (2008). Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. Allergy. 63(6). 742–750. 87 indexed citations
20.
Vyas, Jui, et al.. (1991). Angiomatosis of the breast--a case report with review of literature.. PubMed. 34(4). 296–8. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026